As the EU prepares to introduce regulatory sandboxes for medicines, attention turns to how the new tool can address regulatory hurdles for innovations that do not fit neatly within existing frameworks
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.